Skip to main content
. 2017 Sep 21;8(61):103261–103273. doi: 10.18632/oncotarget.21143

Figure 1. Higher proportion of stem-like cells stands for advanced carcinoma stages.

Figure 1

(A) Tissue slices of 42 from breast cancer patients of different stages were stained with ALDH1 or CD44 antibody respectively to detect the potential stem cells. (B) Adjacent tissues from patients with breast cancer were also stained with ALDH1 or CD44 antibody. (C) Relative intensities of ALDH1 and CD44 were both significant lower in adjacent tissues than those of cancer tissues. (D) Stem cells of ALDH1 or CD44 phenotype were higher in advanced carcinoma, and the p values were indicated in every specific location.